线粒体功能障碍作为一种潜在的机制,在帕金森病中调解心脏并发症
Agustina Salis Torres1,2, Ji-Eun Lee1,3, Andrea Caporali4
1The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian EH25 9RH, UK.
International journal of molecular sciences
|October 26, 2024
概括
帕金森病 (PD) 和心脏功能障碍与线粒体问题有共同的联系. 针对线粒体健康可能为这两种疾病提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
背景情况:
- 帕金森病 (PD) 患者经常经历心脏功能障碍.
- 线粒体功能障碍涉及到PD和心脏问题,表明共享的病理途径.
研究的目的:
- 探索线粒体功能障碍在PD和相关心脏问题的发病过程中的作用.
- 审查线粒体质量控制的机制及其与神经和心脏健康的相关性.
- 确定潜在的治疗点,以减轻PD中的线粒体损伤.
主要方法:
- 文献综述侧重于线粒体生理学,质量控制和疾病机制.
- 在神经和心脏组织中分析线粒体功能障碍的共享途径.
- 综合当前对线粒体在大脑和心脏功能中的作用的理解.
主要成果:
- 线粒体对于神经元和心肌细胞等高能量的组织至关重要.
- 功能障碍的线粒体表现出改变的动力学,生物能学,氧化应激和处理.
- 这些线粒体缺陷是PD中心脏并发症的合理贡献者.
结论:
- 线粒体健康是帕金森病和心脏功能的关键因素.
- 共享的线粒体通路为治疗PD及其心脏并发症提供了潜在的治疗点.
- 旨在改善线粒体质量控制的策略可能有利于患有PD和心脏病的患者.
更多相关视频
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
11.7K
08:19Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
2.4K
相关概念视频
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Electron Transport Chain: Complex I and II
12.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.0K
Mitochondrial Membranes
9.0K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
9.0K
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
